Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Policy Shifts Could Force Firms To Abandon 'Second Brand' Strategies

Executive Summary

India’s new draft pharmaceutical policy proposes a raft of radical changes that have left industry jittery and could force a significant realignment in the operations of foreign and local firms. Second brand strategies and widespread licensing-out of manufacturing are no longer favored, and a 'one company – one drug – one brand name – one price' thrust are among the key changes proposed.

You may also be interested in...



IPA Honors DG Shah With Public-Policy Award

In honor of its former secretary-general DG Shah, the Indian Pharmaceutical Alliance has created a public policy award at the Indian Institute of Management in Ahmedabad.

Top India Drugmakers’ Body Names Industry Veteran Sudarshan Jain New Secretary General

The Indian Pharmaceutical Alliance, which has been at the forefront in representing the interests of the country’s large domestic generic drugmakers, has appointed industry veteran Sudarshan Jain as its new secretary general, replacing founder Dilip Shah who died in February.

Obituary: Dilip Shah, IPA Secretary General

Generics industry veteran and secretary general of the Indian Pharmaceutical Alliance, Dilip Shah, has died aged 77. Shah played a pivotal role in ensuring that the Indian generics industry’s voice was heard.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

GB002142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel